Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Jelfa Pharmaceutical Company

Production, distribution and marketing of solid, semi-solid and injectable preparations.

The company in detail

Summary

Jelfa Pharmaceutical's history dates back to 1945. Soon after the World War II had finished, a group of Polish pioneers, who moved to West Poland, started to operate a small post-German pharmaceutical factory, namely "Labopharma". The first privatisation measures were taken on 2 December 1991 when the firm was transformed into a stock company of the State Treasury; its was also renamed "Polfa" Jelenia Góra. In January of 1994, whilst applying to be listed on the Warsaw Stock Exchange the company changed its name to JELFA Pharmaceutical. The company is focused in the manufacturing of pharmaceuticals for human and veterinary therapy.

Head office

To view this information, you must subscribe to Partneringtools.

Related companies

Related categories

Industry sector
Pharmaceutical / Personal Care
Pharmaceutical / Generics
Pharmaceutical / OTC/Non-Prescription
Pharmaceutical / Prescription
Product development
Packaging
Manufacturing
Therapeutic target
Cardiovascular
Cardiovascular / Acute coronary syndromes / Angina
Cardiovascular / Vascular / Hypertension
Central Nervous System / Psychiatric / Depression
Central Nervous System / Neurodegenerative disorders / Parkinson's disease
Central Nervous System / Neurological / Epilepsy
Central Nervous System / CNS (other) / Smoking cessation
Central Nervous System / Neurological / Sleep disorders
Central Nervous System / Psychiatric / Schizophrenia
Central Nervous System / Psychiatric / Bipolar disorder
Central Nervous System / Neurodegenerative disorders / Alzheimer's disease
Dermatological
Dermatological / Psoriasis
Dermatological / Pruritis
Dermatological / Fungal infection
Dermatological / Acne
Dermatological / Alopecia
Endocrinology
Endocrinology / Hormone replacement therapy
Endocrinology / Hormonal disorder (other)
Endocrinology / Testosterone replacement
Endocrinology / Menopause
Endocrinology / Sex hormone (other)
Genito-urinary / Gender related medicine female / Contraception, female
Infectious diseases / Diseases / Infection, viral (other)
Infectious diseases / Diseases / Infection, fungal (other)
Infectious diseases / Diseases / Urinary tract infection
Infectious diseases / Bacteria or virus / Herpes simplex virus
Infectious diseases / Diseases / Candidiasis
Metabolism
Metabolism / Mineral supplement
Metabolism / Obesity
Metabolism / Hypercholesterolemia
Metabolism / Diabetes type II
Musculoskeletal / Musculoskeletal disorder (other)
Musculoskeletal / Skeletal / Rheumatoid arthritis
Musculoskeletal / Skeletal / Osteoporosis
Partnering consultation free of charge
EuroPLX 38 + 39
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us